Healthcare Transformers authors

Dr. Andrew Wu

Cofounder and CEO of Mesh Bio

Dr. Andrew Wu is the cofounder and CEO of Mesh Bio, a digital health startup providing analytics solutions based on computational biology and AI, for chronic disease diagnosis and management. He was previously Chief Operating Officer of Clearbridge Biomedics (now known as Biolidics) where he developed innovative cancer diagnostics technology in the field of liquid biopsy. He was also Chief Product Officer of Clearbridge Health. Both companies are now listed on CATALIST on the Singapore Exchange. Andrew holds a Bachelors and PhD in Biochemical Engineering from University College London.

More authors

Authors latest publications

Predictive analytics

Predictive analytics: filling the gaps in the patient journey to....

Dr. Andrew Wu,

11 March 2020